ANOVA PANCAN result package

Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:11
iorio@ebi.ac.uk


Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer


Individual drug analysis: 157


Drug details and screening numbers

Drug Name: JNK-9L
Drug ID: 157
Synonyms: KIN001-204
Brand name:
Target: JNK

Number of cell lines screened: 884
Screening concentration range(s): 0.02 to 5.12 uM


Statistically significant associations identified = 4
association id
FEATURE
Drug id
Propr
Public
Drug Name
Drug Target
N FEATURE pos
N FEATURE neg
log max Conc tested
FEATURE neg logIC50 MEAN
FEATURE pos logIC50 MEAN
FEATURE deltaMEAN IC50
FEATURE IC50 effectSize
FEATURE neg Glass delta
FEATURE pos Glass delta
ANOVA FEATURE pval
Tissue ANOVA pval
MSI ANOVA pval
ANOVA FEATURE FDR %
a242
loss_cnaPANCAN233
157
1
1
JNK-9L
JNK
45
836
1.63
-0.304
0.31
0.614
0.58 .
0.59 .
0.46
1.41e-04
2.1e-06
1.59e-02
9.6
a462
loss_cnaPANCAN386
157
1
1
JNK-9L
JNK
56
825
1.63
-0.308
0.247
0.555
0.53 .
0.54 .
0.41
6.01e-04
2.26e-06
1.6e-02
21
a481
gain_cnaPANCAN411_(BLM,CRTC3,FANCI,IDH2,NR2F2,PCSK6)
157
1
1
JNK-9L
JNK
26
855
1.63
-0.294
0.424
0.718
0.68 .
0.69 .
0.53 .
6.68e-04
2.28e-06
1.6e-02
23
a493
loss_cnaPANCAN37
157
1
1
JNK-9L
JNK
32
849
1.63
-0.301
0.47
0.771
0.73 .
0.75 .
0.5
6.99e-04
2.28e-06
1.61e-02
23


All-tests volcano plot